These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 7051136)

  • 1. Electrophysiologic and hemodynamic effects of slow-channel blocking drugs.
    Singh BN; Hecht HS; Nademanee K; Chew CY
    Prog Cardiovasc Dis; 1982; 25(2):103-32. PubMed ID: 7051136
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacological basis for the therapeutic applications of slow-channel blocking drugs.
    Singh BN
    Angiology; 1982 Aug; 33(8):492-515. PubMed ID: 7051905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative electrophysiologic and coronary hemodynamic effects of diltiazem, nisoldipine and verapamil on myocardial tissue.
    Lathrop DA; Valle-Aguilera JR; Millard RW; Gaum WE; Hannon DW; Francis PD; Nakaya H; Schwartz A
    Am J Cardiol; 1982 Feb; 49(3):613-20. PubMed ID: 7058769
    [No Abstract]   [Full Text] [Related]  

  • 4. Calcium channel blocking agents: physiologic basis of nursing intervention.
    Touloukian JE
    Heart Lung; 1985 Jul; 14(4):342-50. PubMed ID: 3891687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential cardiovascular effects of calcium channel blocking agents: potential mechanisms.
    Millard RW; Lathrop DA; Grupp G; Ashraf M; Grupp IL; Schwartz A
    Am J Cardiol; 1982 Feb; 49(3):499-506. PubMed ID: 6277175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of infarcting myocardium by slow channel inhibitors. Comparative effects of verapamil, nifedipine, and diltiazem in the coronary-ligated, isolated working rat heart.
    Hamm CW; Opie LH
    Circ Res; 1983 Feb; 52(2 Pt 2):I129-38. PubMed ID: 6831647
    [No Abstract]   [Full Text] [Related]  

  • 7. Calcium channel blocking agents in congestive heart failure.
    Baughman KL
    Am J Med; 1986 Feb; 80(2B):46-50. PubMed ID: 3511695
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative effects of calcium-channel blocking agents on left ventricular function during acute ischemia in dogs with and without congestive heart failure.
    Urquhart J; Epstein SE; Patterson RE
    Am J Cardiol; 1985 Jan; 55(3):10B-16B. PubMed ID: 3969856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative electrophysiologic effects of bepridil, verapamil and diltiazem in conscious and anesthetized dogs.
    Kantelip JP; Alatienne M; Talmant JM; Ghyselinck N; Duchêne-Marullaz P
    Arch Int Pharmacodyn Ther; 1986 Nov; 284(1):5-18. PubMed ID: 3493741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The haemodynamic effects of nifedipine, verapamil and diltiazem in patients with coronary artery disease. A review.
    Soward AL; Vanhaleweyk GL; Serruys PW
    Drugs; 1986 Jul; 32(1):66-101. PubMed ID: 2874975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac electrophysiologic effects of McN-5691, a new calcium-channel blocking antihypertensive agent.
    Damiano BP; Flaim SF; Gill A; Stump GL; Brannan MD
    J Cardiovasc Pharmacol; 1990 Oct; 16(4):546-56. PubMed ID: 1706795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiologic assessment of calcium channel blockers in transplanted hearts: an experimental study.
    Alvarez L; Escudero C; Torralba A; Millán I
    J Electrocardiol; 1998 Jan; 31(1):51-6. PubMed ID: 9533378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Electrophysiologic effects of calcium channel blocking agents on the sinus node function in anesthetized dogs (author's transl)].
    Nakaya H; Kanno M; Kanda K; Oyama Y
    Nihon Yakurigaku Zasshi; 1980 Nov; 76(8):697-707. PubMed ID: 6268495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
    Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
    Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative cardiac effects of KT-362 and verapamil in isolated heart--correlation to calcium channel current depression.
    Buljubasic N; Marijic J; Stowe DF; Gross GJ; Kampine JP; Bosnjak ZJ
    J Cardiovasc Pharmacol; 1991 Oct; 18(4):594-604. PubMed ID: 1724538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium channel blockade: central hemodynamic effects.
    Ekelund LG
    Acta Pharmacol Toxicol (Copenh); 1986; 58 Suppl 2():59-65. PubMed ID: 2872770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Slow channel calcium antagonists in the treatment of supraventricular tachycardia.
    Talano JV; Tommaso C
    Prog Cardiovasc Dis; 1982; 25(2):141-56. PubMed ID: 6180453
    [No Abstract]   [Full Text] [Related]  

  • 18. Are calcium antagonists cardioprotective?
    Kendall MJ; Horton RC
    J R Coll Physicians Lond; 1985 Apr; 19(2):85-9. PubMed ID: 3889321
    [No Abstract]   [Full Text] [Related]  

  • 19. Differential potentiation by depolarization of the effects of calcium antagonists on contraction and Ca2+ current in guinea-pig heart.
    Okuyama R; Adachi-Akahane S; Nagao T
    Br J Pharmacol; 1994 Oct; 113(2):451-6. PubMed ID: 7834195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Myocardial cellular mechanism of action of calcium antagonists].
    Ferrari R; Boffa GM; Ciampalini G; Ceconi C
    Cardiologia; 1985 Feb; 30(2):77-89. PubMed ID: 3905004
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.